Therapeutic Angiogenesis for Treating Cardiovascular Diseases
Open Access
- 1 January 2012
- journal article
- Published by Ivyspring International Publisher in Theranostics
- Vol. 2 (8), 801-814
- https://doi.org/10.7150/thno.4419
Abstract
Cardiovascular disease is the leading cause of death worldwide and is often associated with partial or full occlusion of the blood vessel network in the affected organs. Restoring blood supply is critical for the successful treatment of cardiovascular diseases. Therapeutic angiogenesis provides a valuable tool for treating cardiovascular diseases by stimulating the growth of new blood vessels from pre-existing vessels. In this review, we discuss strategies developed for therapeutic angiogenesis using single or combinations of biological signals, cells and polymeric biomaterials. Compared to direct delivery of growth factors or cells alone, polymeric biomaterials provide a three-dimensional drug-releasing depot that is capable of facilitating temporally and spatially controlled release. Biomimetic signals can also be incorporated into polymeric scaffolds to allow environmentally-responsive or cell-triggered release of biological signals for targeted angiogenesis. Recent progress in exploiting genetically engineered stem cells and endogenous cell homing mechanisms for therapeutic angiogenesis is also discussed.Keywords
This publication has 62 references indexed in Scilit:
- Tubulogenesis during blood vessel formationSeminars in Cell & Developmental Biology, 2011
- Molecular mechanisms and clinical applications of angiogenesisNature, 2011
- Hypoxia-inducible Vascular Endothelial Growth Factor-engineered Mesenchymal Stem Cells Prevent Myocardial Ischemic InjuryMolecular Therapy, 2011
- Delivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardiumBiomaterials, 2010
- Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesisBiomaterials, 2010
- Combination of chemokine and angiogenic factor genes and mesenchymal stem cells could enhance angiogenesis and improve cardiac function after acute myocardial infarction in ratsMolecular and Cellular Biochemistry, 2010
- Sustained Release of Multiple Growth Factors from Injectable Polymeric System as a Novel Therapeutic Approach Towards AngiogenesisPharmaceutical Research, 2009
- Effects of VEGF temporal and spatial presentation on angiogenesisBiomaterials, 2009
- Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardiumJournal of Molecular and Cellular Cardiology, 2008
- Therapeutic stem and progenitor cell transplantation for organ vascularization and regenerationNature Medicine, 2003